One-Sentence Summary:
hc1 has launched HerCare, a new module in its MyBloodHealth platform, to enhance maternal health by providing real-time lab-driven insights that help prevent anemia-related pregnancy complications.

Three Brief Takeaways:

  • Proactive Maternal Care: HerCare enables clinicians to detect and address anemia in pregnancy before it leads to serious complications.
  • Real-Time Data Analysis: The platform uses lab biomarkers and clinical data to provide immediate, actionable insights for obstetrics teams.
  • Gradual Rollout: HerCare is currently available to select users and will expand to more healthcare systems in late 2025.

hc1 announced the launch of HerCare, a module within its MyBloodHealth platform designed to safeguard maternal health by identifying and addressing health risks associated with anemia in pregnancy. HerCare reflects the company’s commitment to technology that reveals vital health insights hidden in lab data, including those to enhance women’s health and beyond.

HerCare Provides Real-Time Clinical Data

Anemia in pregnancy is a common, yet preventable risk factor that is associated with complications such as post-partum depression, preeclampsia, and pre-term birth. Severe cases can lead to severe bleeding and high blood pressure disorders that pose major risks during childbirth. Through hc1’s HerCare, obstetrics teams can analyze lab biomarkers and clinical data in real time to provide clinicians with actionable insights that prevent serious anemia issues before they become critical.

“As a leader in precision health, HerCare is reshaping maternal care by getting ahead of preventative complications during and after pregnancy,” said hc1 CEO, Founder, and Chairman Bradley Bostic. ” HerCare is an example of how we’re using lab-driven insights to tackle some of the most pressing challenges in maternal care. Through MyBloodHealth and our ongoing work with leading healthcare organizations, we’re closing a critical gap in obstetric care by giving clinicians the tools they need to make informed, often life-saving decisions.”

Rolling out on a Limited Basis

hc1 is rolling out HerCare to current MyBloodHealth customers on a limited basis. The company will offer HerCare more widely to hospital systems and obstetrics practices in late 2025.

HerCare aims to reduce preventable complications by:

  • Early Risk Detection: Identifying patients at risk through real-time monitoring of lab results and clinical data.
  • Personalized Care: Offering tailored insights to guide decisions that enhance patient safety.
  • Clinical Decision Support: Assisting healthcare providers with data-driven recommendations for timely interventions.